Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16ClNO3 |
InChIKeyCQEGUNAVDBBZOH-UHFFFAOYSA-N |
CAS Registry2876921-34-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Preclinical | India | 26 Mar 2025 | |
| Bacterial Infections | Preclinical | India | 26 Mar 2025 |





